Rheumatology
Systematic Review: Epidemiology of musculoskeletal manifestations in pediatric inflammatory bowel disease.
7 Apr, 2022 | 07:55h | UTC
Cohort Study: The five major autoimmune diseases are associated with increased risk of cancer.
6 Apr, 2022 | 09:52h | UTCCommentary: Increased Cancer Risk with Autoimmune Disorders – RheumNow
BSR guideline on management of pediatric, adolescent and adult patients with idiopathic inflammatory myopathy.
4 Apr, 2022 | 01:05h | UTC
Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.
1 Apr, 2022 | 08:45h | UTCCommentary: Network meta-analysis rates treatments for Kawasaki disease – medwire News
RCT: Effect of tacrolimus vs. intravenous cyclophosphamide on complete or partial response in patients with lupus nephritis.
31 Mar, 2022 | 08:18h | UTC
Commentary on Twitter
In this RCT, oral tacrolimus was noninferior to intravenous cyclophosphamide for initial therapy of active lupus nephritis, with a more favorable safety profile. https://t.co/scz7lahVRU
— JAMA Network Open (@JAMANetworkOpen) March 30, 2022
Systematic Review: Interventions for reducing inflammation in familial Mediterranean fever.
30 Mar, 2022 | 10:13h | UTCInterventions for reducing inflammation in familial Mediterranean fever – Cochrane Library
Summary: Medicines for reducing inflammation in people with familial Mediterranean fever – Cochrane Library
What to expect when women with axial spondyloarthritis are expecting: Prevalence of complications of pregnancies in women with axial spondyloarthritis.
30 Mar, 2022 | 10:01h | UTC
Commentary on Twitter
ICYMI: Among 98 women with axSpA, there were 335 pregnancies & 279 live births – 52% uncomplicated and 48% complicated (13%) multiple complications. axSpA had more Preterm birth (13 vs 5%), pre-eclampsia (7 vs 3%), Low birth Wt (8 vs 3%) https://t.co/1oFBKSUzzy pic.twitter.com/oLbYis81Y9
— Dr. John Cush (@RheumNow) March 28, 2022
Review: Challenges in the management of older patients with inflammatory rheumatic diseases.
29 Mar, 2022 | 08:22h | UTCChallenges in the management of older patients with inflammatory rheumatic diseases – Nature Reviews Rheumatology (if the link is paywalled, try this one)
Commentary on Twitter
New content online! Challenges in the management of older patients with inflammatory rheumatic diseases https://t.co/j5a0sQYs6q pic.twitter.com/zhq03boOIN
— NatRevRheumatol (@NatRevRheumatol) March 21, 2022
RCT: Adalimumab introduction vs. methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis.
29 Mar, 2022 | 08:20h | UTCComparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study – The Lancet Rheumatology (link to abstract – $ for full-text)
Commentary: Adalimumab Addition vs. Methotrexate Escalation in Psoriatic Arthritis – RheumNow
Commentary on Twitter
https://twitter.com/TheLancetRheum/status/1498245286795390976
Systematic Review: Management of cervical spondylotic radiculopathy.
28 Mar, 2022 | 08:30h | UTCManagement of Cervical Spondylotic Radiculopathy: A Systematic review – Global Spine Journal
Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes.
28 Mar, 2022 | 08:28h | UTC
3 orthopedic surgeries that might be doing patients (and their pockets) more harm than good.
25 Mar, 2022 | 09:54h | UTC
Biomarkers may be an early warning sign for the presence of giant cell arteritis in patients with polymyalgia rheumatica.
24 Mar, 2022 | 08:17h | UTCCommentary: Biomarkers may improve giant cell arteritis diagnosis – medwireNews
Commentary on Twitter
In our newest paper we investigated biomarkers that aid the diagnosis of Giant Cell Arteritis versus PMR or other mimicing conditions. This time, we worked together with our colleagues in Aarhus, Denmark to measure the biomarkers in 2 independent cohortshttps://t.co/d6PWsGSl2H
— Yannick van Sleen (@SleenYannick) March 11, 2022
Inflammatory eye disease: An overview of clinical presentation and management.
24 Mar, 2022 | 08:07h | UTC
An update on the clinical approach to giant cell arteritis.
24 Mar, 2022 | 08:03h | UTCAn update on the clinical approach to giant cell arteritis – Clinical Medicine Journal
Phase 2 trial of Iberdomide in systemic lupus erythematosus.
22 Mar, 2022 | 08:27h | UTCPhase 2 Trial of Iberdomide in Systemic Lupus Erythematosus – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Mixed Results for Oral Lupus Drug in Phase II— Mid-stage study offers hope but also reason for caution – MedPage Today (free registration required)
Commentary on Twitter
In patients with systemic lupus erythematosus, iberdomide at the highest dose, but not at lower doses, was superior to placebo with respect to the primary end point of an SRI-4 response at 24 weeks. https://t.co/rie3SRhoew pic.twitter.com/wRre5Gp1xB
— NEJM (@NEJM) March 17, 2022
M-A: Rheumatoid arthritis in spine surgery.
21 Mar, 2022 | 08:19h | UTCRheumatoid Arthritis in Spine Surgery: A Systematic Review and Meta-Analysis – Global Spine Journal
Cohort Study: Association between long-term exposure to air pollution and immune-mediated diseases.
17 Mar, 2022 | 08:40h | UTCNews Release: Long term exposure to air pollution linked to heightened autoimmune disease risk – BMJ Newsroom
Commentaries:
Air pollution linked to higher risk of autoimmune diseases – The Guardian
Breathing Dirty Air Could Raise Your Odds for Rheumatoid Arthritis – HealthDay
Cohort Study: TNF inhibitors increase the risk of nontuberculous mycobacteria in patients with seropositive rheumatoid arthritis in a mycobacterium tuberculosis endemic area.
16 Mar, 2022 | 08:44h | UTC
Review | Resistance exercise as a treatment for sarcopenia: prescription and delivery.
15 Mar, 2022 | 09:55h | UTCResistance exercise as a treatment for sarcopenia: prescription and delivery – Age and Ageing
Updated guideline summary introduces new recommendations for use of medications around total hip and knee replacement.
10 Mar, 2022 | 10:45h | UTCGuideline Summary (full guideline not available yet): 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients with Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty – American College of Rheumatology
RCT: Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis.
10 Mar, 2022 | 10:27h | UTCComparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial – The Lancet Rheumatology (link to abstract – $ for full-text)
Commentary: COMPLETE-PsA: Adding leflunomide to methotrexate may improve outcomes – medwireNews
Commentary on Twitter
NEW RESEARCH—A double-blind, placebo-controlled, randomised, trial comparing #methotrexate monotherapy with methotrexate plus #leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA) https://t.co/Fln7RlNl36 #LancetRheumatology pic.twitter.com/EqWSeHZQA2
— The Lancet Rheumatology (@TheLancetRheum) March 3, 2022
ACR/Vasculitis Foundation Guideline for the management of Kawasaki Disease.
9 Mar, 2022 | 10:01h | UTC
Bisphosphonate nephropathy: A case series and review of the literature.
9 Mar, 2022 | 08:32h | UTC
Guideline for perioperative management of patients with inflammatory rheumatic diseases.
8 Mar, 2022 | 08:43h | UTC